Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as ...

Next, the team evaluated the effects of soluble TfR, anti-TfR antibody, and SL8 and QK8 peptides on SARS-CoV-2 infection using reverse-transcription polymerase chain reaction (RT-PCR) and plaque ...

The new XFG variant of COVID-19 is part of the natural evolution of the SARS-CoV-2 virus, warns former ICMR chief Dr. Bhargava. With over 200 cases recorded in India, find out what this means for ...

Symptomatic SARS-CoV-2 infection through day 14 was confirmed by means of a RT-PCR assay or rapid antigen test in 2.6% of the participants in the 5-day nirmatrelvir–ritonavir group, 2.4% of ...

The study consisted of 145,199 SARS-CoV-2-positive individuals and 325,715 SARS-CoV-2 vaccine recipients, of whom 167,337 and 158,378 were CoronaVac and BNT162b2 recipients, respectively.

Unfounded claims about SARS-CoV-2’s origin continue to circulate, further complicating efforts to maintain a constructive, evidence-based public discourse.

The Biden administration’s Project NextGen will coordinate a whole-of-government effort to advance needed innovations in SARS-CoV-2 vaccines and treatments.

The presence of mRNA for SARS-CoV-2 N protein correlated with a significant increase in the inflammatory markers of NOD-like receptor family pyrin domain-containing 3 and tumor necrosis factor.

A new study uncovers a surprising mechanism by which the SARS-CoV-2 virus, responsible for COVID-19, might cause immune-mediated tissue damage by targeting cells it has never infected.

To determine whether multiple SARS-CoV-2 infections impact the risk for long COVID, Clouston and colleagues retrospectively studied data from 2,511 essential workers in New York, most of whom were ...